Trial Profile
Phase III trial of oral capsule formulation of Hep-114 in patients with toxic liver damage
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Feb 2016
Price :
$35
*
At a glance
- Drugs Hep 114 (Primary)
- Indications Liver injury
- Focus Registrational; Therapeutic Use
- 11 Feb 2016 Status changed from recruiting to completed, as per TGV-Laboratories media release.
- 06 Apr 2015 New trial record